Cargando…
Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies
Chemotherapy-induced thrombocytopenia (CIT) is a common complication of the treatment of non-hematologic malignancies. Many patient-related variables (e.g., age, tumor type, number of prior chemotherapy cycles, amount of bone marrow tumor involvement) determine the extent of CIT. CIT is related to t...
Autor principal: | Kuter, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152964/ https://www.ncbi.nlm.nih.gov/pubmed/35642485 http://dx.doi.org/10.3324/haematol.2021.279512 |
Ejemplares similares
-
A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumor s and hematologic malignancies
por: Al-Samkari, Hanny, et al.
Publicado: (2020) -
Treatment of drug-induced immune thrombocytopenias
por: Marini, Irene, et al.
Publicado: (2022) -
Treatment of inherited thrombocytopenias
por: Balduini, Carlo L.
Publicado: (2022) -
The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies
por: Shaw, Jaime L., et al.
Publicado: (2021) -
Fusariosis in patients with hematological malignancies: Two case reports
por: Raymakers, Jord W., et al.
Publicado: (2023)